Intellia Therapeutics Inc (NTLA)
SG&A Expenses
$37.82M
Quarterly · Period ending: · USD
NTLA SG&A Expenses
Latest reported$37.82Mperiod ending
Latest reported$37.82Mperiod ending
NTLA Quarterly SG&A Expenses ($167.00K → $37.82M)
Quarterly SG&A Expenses
High-resolution chart · PNG
NTLA sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 37,824,000 | |
| 34,843,000 | |
| 33,075,000 | |
| 46,310,000 | |
| 43,708,000 | |
| 29,007,000 | |
| 32,444,000 | |
| 44,707,000 | |
| 31,793,000 | |
| 31,091,000 | |
| 28,994,000 | |
| 29,403,000 | |
| 30,652,000 | |
| 27,448,000 | |
| 23,626,000 | |
| 22,145,000 | |
| 22,132,000 | |
| 22,403,000 | |
| 22,108,000 | |
| 18,711,000 | |
| 16,683,000 | |
| 13,594,000 | |
| 10,763,000 | |
| 10,566,000 | |
| 11,526,000 | |
| 11,314,000 | |
| 8,976,000 | |
| 8,431,000 | |
| 13,118,000 | |
| 10,533,000 | |
| 8,708,000 | |
| 8,270,000 | |
| 7,805,000 | |
| 7,406,000 | |
| 10,213,000 | |
| 5,711,000 | |
| 6,369,000 | |
| 5,732,000 | |
| 5,118,000 | |
| 4,705,000 | |
| 3,729,000 | |
| 3,246,000 | |
| 2,809,000 | |
| 1,531,000 | |
| 2,833,000 | |
| 1,110,000 | |
| 2,714,500 | |
| 167,000 |